GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (NEOE:PFE) » Definitions » Cyclically Adjusted PB Ratio

Pfizer (NEOE:PFE) Cyclically Adjusted PB Ratio : 1.86 (As of May. 02, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Pfizer Cyclically Adjusted PB Ratio?

As of today (2024-05-02), Pfizer's current share price is C$12.71. Pfizer's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was C$6.83. Pfizer's Cyclically Adjusted PB Ratio for today is 1.86.

The historical rank and industry rank for Pfizer's Cyclically Adjusted PB Ratio or its related term are showing as below:

NEOE:PFE' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.75   Med: 2.87   Max: 4.7
Current: 1.87

During the past years, Pfizer's highest Cyclically Adjusted PB Ratio was 4.70. The lowest was 1.75. And the median was 2.87.

NEOE:PFE's Cyclically Adjusted PB Ratio is ranked better than
51.29% of 657 companies
in the Drug Manufacturers industry
Industry Median: 1.8 vs NEOE:PFE: 1.87

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pfizer's adjusted book value per share data for the three months ended in Dec. 2023 was C$8.142. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is C$6.83 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pfizer Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Pfizer's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Cyclically Adjusted PB Ratio Chart

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.08 3.04 4.59 3.69 1.98

Pfizer Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.87 2.54 2.28 1.98 -

Competitive Comparison of Pfizer's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, Pfizer's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Cyclically Adjusted PB Ratio falls into.



Pfizer Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Pfizer's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=12.71/6.83
=1.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Pfizer's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=8.142/129.4194*129.4194
=8.142

Current CPI (Dec. 2023) = 129.4194.

Pfizer Quarterly Data

Book Value per Share CPI Adj_Book
201403 5.199 99.695 6.749
201406 5.037 100.560 6.483
201409 5.245 100.428 6.759
201412 5.029 99.070 6.570
201503 5.322 99.621 6.914
201506 5.161 100.684 6.634
201509 5.527 100.392 7.125
201512 5.531 99.792 7.173
201603 5.184 100.470 6.678
201606 5.134 101.688 6.534
201609 5.262 101.861 6.686
201612 5.035 101.863 6.397
201703 5.055 102.862 6.360
201706 5.021 103.349 6.288
201709 4.817 104.136 5.987
201712 5.861 104.011 7.293
201803 5.872 105.290 7.218
201806 6.012 106.317 7.318
201809 6.189 106.507 7.520
201812 5.735 105.998 7.002
201903 5.445 107.251 6.570
201906 5.477 108.070 6.559
201909 5.998 108.329 7.166
201912 5.783 108.420 6.903
202003 6.292 108.902 7.477
202006 6.043 108.767 7.190
202009 5.981 109.815 7.049
202012 5.601 109.897 6.596
202103 5.935 111.754 6.873
202106 5.885 114.631 6.644
202109 6.580 115.734 7.358
202112 6.769 117.630 7.447
202203 7.185 121.301 7.666
202206 7.685 125.017 7.956
202209 8.476 125.227 8.760
202212 8.908 125.222 9.207
202303 9.422 127.348 9.575
202306 8.971 128.729 9.019
202309 8.943 129.860 8.913
202312 8.142 129.419 8.142

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pfizer  (NEOE:PFE) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Pfizer Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Pfizer's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer (NEOE:PFE) Business Description

Industry
Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer (NEOE:PFE) Headlines